|
|
| | | What you need to know about the coronavirus today |
| |
China plans to extend flight curbs Chinese civil aviation authorities plan to extend until June 30 their curbs on international flights to contain the spread of the coronavirus, the U.S. embassy in Beijing said in a travel advisory on Friday. China has drastically cut such flights since March to allay concerns over infections brought by arriving passengers. A so-called "Five One" policy allows mainland carriers to fly just one flight a week on one route to any country and foreign airlines to operate just one flight a week to China.
Fighting misinformation It's not just U.S. President Donald Trump's tweets that are being fact-checked. Twitter has also flagged a tweet written in March by Chinese Foreign Ministry spokesman Zhao Lijian that suggested the U.S. military brought the novel coronavirus to China, posting a blue exclamation mark under it with a comment urging readers to check the facts about COVID-19.
Closed climbing season Nepal's Sherpa guides, famed for being the backbone of mountain expeditions in the Himalayas, have also found their livelihood hit by the coronavirus outbreak. Many have returned to their villages, hiking officials say, as climbing and trekking activities have been suspended since March, and some are looking ahead with hope to the less popular autumn climbing season, which lasts from September to November. | |
| |
| |
Reuters reporters and editors around the world are investigating the response to the coronavirus pandemic.
We need your help to tell these stories. Our news organization wants to capture the full scope of what’s happening and how we got here by drawing on a wide variety of sources. Here’s a look at our coverage.
Are you a government employee or contractor involved in coronavirus testing or the wider public health response? Are you a doctor, nurse or health worker caring for patients? Have you worked on similar outbreaks in the past? Has the disease known as COVID-19 personally affected you or your family? Are you aware of new problems that are about to emerge, such as critical supply shortages?
We need your tips, firsthand accounts, relevant documents or expert knowledge. Please contact us at coronavirus@reuters.com.
We prefer tips from named sources, but if you’d rather remain anonymous, you can submit a confidential news tip. Here’s how. | |
|
| |
|
|
|
| | Life under lockdown |
When Yahaira Caraballo opened her nail salon in the Bronx, New York, nearly seven years ago, it was a bare-bones shop with two nail technicians. Earlier this year, she had six nail technicians, a full-time receptionist and a cleaning person, a renovated salon, and a following that included as many as 45 clients on a busy day. Now Caraballo doesn’t know how long it will be before her clients can once again sit side by side at her black shimmery nail bar for manicures, or on her salon’s long studded bench to have pedicures. 4 min read | |
The black leather party masks that performers May and Som wear for their fetish shows in Bangkok are definitely not the sort to stop the coronavirus. Behind closed doors, they practise for the day when health restrictions are lifted and tourists return, but they have no idea when and worry that the city’s infamous Patpong red-light district could be very different by then. 4 min read | |
| Covid Science |
The European health regulator has vowed to conduct a speedy review of Gilead Sciences’ potential COVID-19 drug, remdesivir, but said it has not yet received an application from the U.S. drugmaker. A pharmaceutical company in Pakistan plans to import the antiviral drug remdesivir, which has shown promise in treating coronavirus patients, from neighbouring Bangladesh, it said in a stock exchange filing. 4 min read | |
Drugmaker Sun Pharmaceutical said on Friday it has received Indian regulatory approval to start clinical trials of a pancreatitis drug in COVID-19 patients. The company joins other Indian drugmakers Glenmark Pharmaceuticals and Strides Pharma Science that are conducting trials in India for potential drugs for COVID-19, which currently has no approved treatment or vaccine. 2 min read | |
|
| |
|
|
| | Top Stories on Reuters TV |
|
| |
|
|
|